Aarti Drugs is engaged in the manufacturing and marketing in active Pharmaceutical Ingredients , Pharma Intermediates and Specialty Chemicals. Having a pharma company always has its advantages now due to current ever increasing health issues. I expect a 10% move in the next 6 months.
The Stock witnessed a five-wave impulsive rise beginning in March 2023 and ending in July 2023.
The impulse move led to a 105% rally in the stock in a matter of just 5 months.
Since the completion of the wave 1 in July however, the stock went into the corrective wave 2 structure between July-October. The corrective phase can be marked as an Elliot wave...
Please look into the chart for a detailed understanding.
Consider these for short-term & swing trades with 2% profit.
For BTST trades consider booking
target for 1% - 2%
For long-term trades look out for resistance drawn above closing.
Please consider these ideas for educational purpose
Aarti drugs making Inverter head & sholder pattern, if break out it this pattern than Target to upside 700 level & SL to be bellow 438.
Only for education purpose
Showing signs of reversal and crossing over of 5,20,50 SMA on monthly time frame shows positivity.
Safe entry would be above 515 where candle enters 1/1 damn angle and breaks out of the important Gann levels
Buy above :- 471
Stop loss :- 409
Target:- 530
Time :- 45 trading days
Aarti Drugs Limited is a pharmaceutical company which manufactures bulk drugs and specialty chemicals.
Aarti drugs limited is a pharmaceutical & biotechnology company engaged in manufacturing of APIs (Active Pharmaceutical Ingredients), Pharma Intermediates & Specialty chemicals. With strong Research and Development (R&D) and GMP certified manufacturing units the company aims to provide quality and effective solutions to their clients PAN India.
CMP of the stock...
The company is engaged in the manufacturing of Active Pharmaceutical Ingredients (APIs), Pharma Intermediates, Specialty Chemicals and also produces Formulations with its wholly-owned subsidiary - Pinnacle Life Science Private Limited.
Products under APIs includes Ciprofloxacin Hydrochloride, Metronidazole, Metformin HCL, Ketoconazole, Ofloxacin etc. whereas...
Aarti drugs is on the verge of breaking the trendline after consolidating for a long time.The consolidation happens after a flag pole, which is a strong indication of an uptrend movement. And the volume gives an additional suppport to the idea.
Hope it reach above 1000pts. :)
X/2 Entry in Aarti Drugs can be taken after closing above 467 and second X/2 entry can be taken after closing above 475. Targets will be 489 and 510. Long term target in the company will be 531. Stop loss in the company can be maintained at a closing below 440. Aarti Drugs Ltd. is a manufacturer of APIs Pharma intermediates and specialty chemicals. Negative of...
NSE:AARTIDRUGS is sustained above important support level. My idea is to take buy entry at level of 455 with stop loss of 435 (-20 Points).My expected upside target will be 478 & 518.
Note: This is my personal analysis, only for learning. Thanks.
